Royalty Pharma
RPRX
$28.21
Share price
0.50%
Change (1 day)
-17.83%
Change (1 year)
Categories
Operating Margin for Royalty Pharma (RPRX)
Operating Margin as of May 2024 (TTM): 27.89%
According to Royalty Pharma's latest financial reports and stock price the company's current Operating Margin is 27.89%. At the end of 2022 the company had an Operating Margin of 10.28%.
Operating Margin history for Royalty Pharma from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 10.28% | -81.03% |
| 2021 | 54.21% | -32.41% |
| 2020 | 80.21% | -40.88% |
| 2019 | 135.67% | 60.43% |
| 2018 | 84.57% | 0.6% |
| 2017 | 84.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 15.60% | -44.07% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -11.58% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | -9.64% | -134.56% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.